Corporate Ownership Data

← Data Explorer · All industries

Drugs (SIC 283)

Major group 28: Chemicals and allied products

Companies whose SIC industry code starts with 283. Companies with no code (SIC 0) and shell companies (SIC 9995) are left out.

Its 4-digit industries: 2833 Medicinal chemicals & botanical products · 2834 Pharmaceutical preparations · 2835 In vitro & in vivo diagnostic substances · 2836 Biological products, (no diagnostic substances)

As of2020 Q4
Data cover 2000 Q4 – 2020 Q4, quarterly.
S&P 500 companies All companies

The tiles, heatmap and tables below use the industry’s S&P 500 companies.

Companies in 2020 Q4 17
Average profit weight between them 0.51

Average profit weight in the industry over time

The mean profit weight over every ordered pair of the industry’s companies, each quarter: S&P 500 companies (solid) and all companies (faded). Click a quarter to show it.

    Computed from the current data release, using every firm in the sample. Published papers used earlier releases and samples, so their figures differ slightly.

    Show the numbers

    Profit weights between the 17 largest companies, 2020 Q4

    Each cell is the profit weight of the row company’s shareholders on the column company (darker: higher). Companies are ordered so that tightly linked groups form blocks. Largest means most reported owners. Click a cell to compare the two companies.

    Aligos Therapeutics I…Hookipa Pharma IncIncyte CorpLilly Eli & CoRegeneron Pharmaceuti…Gilead Sciences IncI D E X X Laboratorie…Viatris IncCatalent IncVertex Pharmaceutical…Biogen IncAbbvie IncAmgen IncZoetis IncAlexion Pharmaceutica…Baxter International …Tilray Inc
    Aligos Therapeutics Inc 0.100.360.150.160.080.090.220.170.180.160.080.090.080.130.260.00
    Hookipa Pharma Inc 0.080.180.130.310.110.120.130.120.200.130.120.150.150.180.110.00
    Incyte Corp 0.230.160.280.350.360.360.350.570.500.330.290.310.310.380.360.00
    Lilly Eli & Co 0.200.180.570.600.520.520.550.570.590.620.450.540.500.490.540.01
    Regeneron Pharmaceuticals Inc 0.180.350.600.510.800.560.600.600.800.540.520.650.620.560.610.01
    Gilead Sciences Inc 0.080.110.530.370.670.490.510.560.650.400.450.610.500.410.530.01
    I D E X X Laboratories Inc 0.130.180.820.580.740.770.750.890.820.700.660.730.740.730.680.01
    Viatris Inc 0.360.220.870.670.870.870.820.810.870.780.680.780.720.740.870.01
    Catalent Inc 0.150.110.780.380.470.520.530.440.670.440.440.450.460.470.430.01
    Vertex Pharmaceuticals Inc 0.220.260.980.560.900.860.700.680.960.640.600.700.700.640.690.01
    Biogen Inc 0.220.180.690.640.650.570.650.660.680.680.530.690.580.640.620.01
    Abbvie Inc 0.200.331.160.871.181.221.141.071.291.211.001.101.061.051.000.02
    Amgen Inc 0.170.280.870.751.071.180.900.890.951.020.930.790.880.830.870.01
    Zoetis Inc 0.130.290.860.680.990.940.900.800.951.000.760.740.860.810.790.01
    Alexion Pharmaceuticals Inc 0.230.351.040.650.890.760.870.810.940.890.830.730.800.800.720.02
    Baxter International Inc 0.370.160.770.570.760.780.640.760.690.760.640.550.670.620.570.02
    Tilray Inc 0.000.010.020.020.030.030.020.030.030.030.030.020.030.030.030.04

    Investors who drive it, 2020 Q4

    The investors that contribute most to the industry’s average profit weight: roughly, those holding sizeable stakes in many of its companies at once. Owner types follow the forms each investor files with the SEC: 13F, Forms 3/4/5, 13D or 13G, in that order of precedence (an investor that files both 13F and Forms 3/4/5, such as Carl Icahn, counts as a 13F filer). Big Three is Vanguard, BlackRock and State Street.

    • Big Three
    • 13F filers
    • 13G filers
    • 13D filers
    • Forms 3/4/5 filers
    #InvestorTypeCompanies held hereShare of the averageSEC CIK
    1 Vanguard Group Inc Big Three 1734% 102909
    2 BlackRock Inc. Big Three 1731% 1364742
    3 State Street Corp Big Three 178% 93751
    4 Capital International Inc /Ca/*Capital International Investors 13F filer 127% 732812
    5 Wellington Management Group LLP 13F filer 154% 902219
    6 FMR LLC 13F filer 163% 315066
    7 Price T Rowe Associates Inc /MD/ 13F filer 143% 80255
    8 Geode Capital Management, LLC 13F filer 171% 1214717
    9 Franklin Resources Inc*Brandywine Global Investment Management, Llc*Legg Mason Asset Management (Japan) Co., Ltd.*Clearbridge Investments, LLC 13F filer 150.8% 38777
    10 Northern Trust Corp 13F filer 170.7% 73124
    11 Baker Bros. Advisors LP 13F filer 40.7% 1263508
    12 JPMorgan Chase & Co 13F filer 170.7% 19617
    13 Janus Henderson Group PLC 13F filer 150.5% 1274173
    14 Norges Bank 13F filer 140.5% 1374170
    15 Morgan Stanley 13F filer 170.4% 895421
    16 Bank of New York Mellon Corp 13F filer 170.4% 1629943
    17 Primecap Management Co/Ca/ 13F filer 30.4% 763212
    18 Bank of America Corp /DE/ 13F filer 170.4% 70858
    19 UBS Asset Management Americas Inc*Ubs Group AG 13F filer 170.3% 1610520
    20 Alliancebernstein L.P. 13F filer 150.3% 1109448
    21 Nuveen Asset Management, LLC 13F filer 170.3% 1521019
    22 Legal & General Group PLC 13F filer 170.2% 764068
    23 Renaissance Technologies LLC 13F filer 100.2% 1037389
    24 Invesco LTD. 13F filer 140.1% 914208
    25 Wells Fargo & Company/Mn 13F filer 170.1% 72971

    The companies, 2020 Q4

    CompanyReported ownersReported ownershipSEC CIK
    Abbvie Inc SIC 2836 · S&P 500 246767.88%1551152
    Amgen Inc SIC 2836 · S&P 500 204775.93%318154
    Lilly Eli & Co SIC 2834 · S&P 500 · outlier 175782.39%59478
    Gilead Sciences Inc SIC 2836 · S&P 500 148377.96%882095
    Zoetis Inc SIC 2834 · S&P 500 134591.02%1555280
    Viatris Inc SIC 2834 · S&P 500 115777.03%1792044
    Baxter International Inc SIC 2834 · S&P 500 106188.58%10456
    Biogen Inc SIC 2836 · S&P 500 99784.51%875045
    Vertex Pharmaceuticals Inc SIC 2834 · S&P 500 91491.99%875320
    I D E X X Laboratories Inc SIC 2835 · S&P 500 90787.28%874716
    Regeneron Pharmaceuticals Inc SIC 2834 · S&P 500 · dual class 84587.02%872589
    Alexion Pharmaceuticals Inc SIC 2836 · S&P 500 79290.48%899866
    Catalent Inc SIC 2834 · S&P 500 518105.5%1596783
    Incyte Corp SIC 2836 · S&P 500 49793.18%879169
    Tilray Inc SIC 2834 · S&P 500 · dual class 20835.48%1731348
    Hookipa Pharma Inc SIC 2836 · S&P 500 · dual class 7167.30%1760542
    Aligos Therapeutics Inc SIC 2836 · S&P 500 · dual class 5271.48%1799448

    Something look wrong? Report a problem with this page. How to report.

    These pages are for looking up individual companies and investors. Please don’t copy them with automated tools. If you need the full data, request a download: it is free of charge for academic research.